Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 20 Issue 7, July 2014

Neisseria meningitidis infection that enters the bloodstream can cause potentially fatal meningitis and septic shock. The host cell receptor that enables its adhesion to blood vessels and subsequent vascular colonization is not known. In this issue, Bernard et al. identify CD147 as an endothelial cell receptor that mediates meningococcal adhesion to and colonization of human blood vessels (p 725). The cover image depicts N. meningitidis (pink) colonizing human blood vessels (basal lamina collagen IV, green, and actin, blue) in human skin grafted onto a mouse. Image courtesy of Sandrine Bourdoulous, Institut Cochin.

Editorial

  • Current drug approval regulations in Europe and the United States require that the treatment group demonstrates a clear benefit compared with the control group. These laws should be updated to reflect patient heterogeneity in clinical trials, and allow for approval of drugs that show efficacy in only a subset of treated patients.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Q&A

  • Last month, Martin Stratmann began a six-year term as president of the Munich-based Max Planck Society. Stratmann spoke with David Levine about his vision for the society and about what the change of guard will mean for biomedical research.

    Q&A
Top of page ⤴

News in Brief

Top of page ⤴

News Feature

  • The only vaccine ever approved to protect against Lyme disease was pulled off the market in 2002, and drugmakers have yet to offer an alternative. What's taking so long? Cassandra Willyard investigates.

    • Cassandra Willyard
    News Feature
Top of page ⤴

Book Review

Top of page ⤴

News & Views

  • Diamond-Blackfan anemia (DBA) is an inherited hypoplastic anemia characterized by impaired production of erythroid cells, and it is caused by inactivating mutations in ribosomal protein genes in more than half of all cases. A new study in human cells demonstrates that reduced translation of the transcription factor GATA1, as a consequence of ribosomal protein haploinsufficiency, is a crucial factor in mediating the erythroid defect found in DBA (pages 748–753).

    • Jacqueline Boultwood
    • Andrea Pellagatti
    News & Views
  • Leptin deficiency, which is associated with type 1 diabetes, is a critical factor in the pathophysiology of this disease, a new study in rats shows. The lack of this hormone triggers a cascade of neuroendocrine events that affect adipose tissue and the liver, resulting in hyperglycemia and ketoacidosis (pages 759–763).

    • Bettina Mittendorfer
    • Samuel Klein
    News & Views
  • Stress has long been thought to be a major contributing factor to cardiovascular disease, although little is known about the underlying cellular mechanisms. A new study in humans and mice suggests that chronic stress promotes hematopoietic stem cell proliferation in bone marrow, leading to increased leukocyte production, circulation and recruitment to the vasculature (pages 754–758).

    • Richard N Hanna
    • Catherine C Hedrick
    News & Views
Top of page ⤴

Between Bedside and Bench

  • Oxidative stress has long been linked to disease development and accelerated aging, prompting professionals in the biomedical field to suggest the use of antioxidants to prevent or even reverse these conditions. But growing clinical evidence is showing that this in fact might not be effective, calling for additional investigation to prove that certain molecular factors involved in oxidation, specifically reactive oxidative species (ROS), are not detrimental. In “Bedside to Bench,” Michael Ristow highlights recent human studies with antioxidant supplementation that have failed to show any improvement in health span. Moreover, other relevant evidence has pointed towards a beneficial role for ROS in lifespan under stress conditions, although how this is mediated and regulated inside the cell is not fully understood. In “Bench to Bedside,” Hiroyuki Kawagishi and Toren Finkel peruse the biological and signaling underpinnings of ROS in living organisms, which suggest different amounts of ROS may explain their dual role in lifespan and disease and the lack of effect of antioxidants in the body. The authors propose targeting pathways and molecules involved in removing cellular damage rather than ROS, which could make therapies to increase lifespan more effective and preclude diseases caused by oxidation and aging.

    • Michael Ristow
    Between Bedside and Bench
Top of page ⤴

Research Highlights

Top of page ⤴

Article

  • Mounia Tannour-Louet and her colleagues show that 1–3% of cases of male genitourinary tract malformations are associated with increased copy number variations of the VAMP7 gene, which encodes a SNARE protein involved in vesicular transport. They show that overexpression of human VAMP7 in mice is sufficient to replicate the condition in this species and that the phenotype is due to alterations in the balance between androgen and estrogen signaling.

    • Mounia Tannour-Louet
    • Shuo Han
    • Dolores J Lamb
    Article
  • Neisseria meningitidis is the causative agent of potentially fatal meningitis and septic shock, induced by bacterial colonization of blood vessels in the brain and the periphery. The endothelial cell receptor mediating meningococcal adhesion to blood vessels has previously been unknown. Here Sandrine Bourdoulous and colleagues report that CD147 expressed on human endothelial cells is a crucial mediator of N. meningitidis vascular colonization, providing new insight into some of the mechanisms that give rise to meningococcal disease.

    • Sandra C Bernard
    • Nandi Simpson
    • Sandrine Bourdoulous
    Article
Top of page ⤴

Letter

Top of page ⤴

Technical Report

  • Modeling and documenting malignant progression in vitro without the need for in vivo transplantation represents a clear step forward for cancer investigation. Using an air-liquid interface methodology, Xingnan Li and colleagues show they can robustly model a range of gastrointestinal malignancies from pancreas, stomach and colon in primary epithelial/mesenchymal organoid culture. This setup is able to generate detailed histologic endpoints for oncogenic transformation in vitro and demonstrate in vivo tumorigenicity when the organoids are transplanted.

    • Xingnan Li
    • Lincoln Nadauld
    • Calvin J Kuo
    Technical Report
  • Multidrug and radiation resistance, as well as nonspecific toxic effects of some drugs, currently limit some cancer therapies. Ekaterina Lukianova-Hleb and colleagues address this with the development of an intracellular drug release system using plasmonic nanobubbles for the on-demand release of the encapsulated payload from nanocarriers, achieving high target cell specificity and intracellular concentration and enhanced therapeutic efficacy of both drugs and X-rays. Validation is shown in aggressive and multidrug resistant head and neck squamous cell carcinoma using encapsulated doxorubicin and paclitaxel.

    • Ekaterina Y Lukianova-Hleb
    • Xiaoyang Ren
    • Dmitri O Lapotko
    Technical Report
Top of page ⤴

Search

Quick links